Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis (Q82299259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

J S Hwang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

S T Tu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

T S Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J F Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C J Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

19 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

373-378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study

15 January 2020

cites work

1 reference

12 December 2020

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

12 December 2020

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Effect of different doses of nasal salmon calcitonin on bone mass

1 reference

12 December 2020

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers

1 reference

12 December 2020

Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women

1 reference

12 December 2020

Osteoporosis: prevalence in Taiwanese women

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Parathyroid hormone for treatment of osteoporosis

1 reference

12 December 2020

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

12 December 2020

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

1 reference

12 December 2020

Epidemiology of osteoporosis in Taiwan

1 reference

12 December 2020

Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy

1 reference

12 December 2020

Long-term calcitonin therapy in postmenopausal osteoporosis

1 reference

12 December 2020

Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects

1 reference

12 December 2020

Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis

1 reference

12 December 2020

Vertebral fracture assessment using a semiquantitative technique.

1 reference

12 December 2020

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

12 December 2020

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

1 reference

12 December 2020

10.1007/S00198-005-2002-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16421647%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference